Innovation Convention: results
Do not extinguish the generation
Irik Imamutdinov, Galina Kostina, Dan Medovnikov, Tigran Oganesyan
(With abbreviations: descriptions of projects unrelated to biomedicine can be read in the full text of the article on the website of the Expert magazine.)
On the ninth-tenth of December, the first annual Russian Youth Innovation Convention was held at
Vyacheslav Muravyev, the head of the project "Development of a miniature semiconductor generator and a terahertz radiation detector" from the Institute of Solid State Physics near Moscow (Chernogolovka), received the award in the nomination "Best Invention".
Hermes Chilov, the head of the project "Software package for the development of new medicines", developed by employees and graduate students of the Faculty of Chemistry of Moscow State University, won in the nomination "Innovative project".
The best innovative manager was Nikolay Dobrovolsky with the Parallels Desktop for Mac project, the world's first product that allowed Windows to run efficiently on Macintosh computers.
The Zvorykin Prize was also awarded to: in the nomination "International recognition" — Pavel Troshin (research area: organic synthesis, materials science, organic electronics, energy conversion). In the nomination "Information support of innovative economy" — the magazine "Popular mechanics". Each winner received a cash prize of 1 million rubles.
Hermes is preparing a revolutionYoung innovator Hermes Chilov received the award for the best innovative project.
He created the company "Molecular Technologies", which developed a program for modeling the interaction of potential drugs with target proteins. It is known that pharmaceutical companies spend a lot of time and money searching for the best candidates for new medicines. Molecular modeling is one of the methods they use along with more traditional ones, for example, screening of known low—molecular compounds, which is much more expensive than modeling. The new method has not yet proven its effectiveness, so it causes some skepticism. But Hermes Chilov intends to defeat this skepticism. Already, the Moltech program is more successful than that of global competitors, it is being tested in the world's largest pharmaceutical companies.
Hermes Chilov was born in Vologda 30 years ago. His first hobby in early childhood, as far as he remembers, was astronomy. Mom bought
Once at Moscow State University, Hermes did not feel in this temple of science the magic that accompanied him during his studies at the lyceum. Unfortunately for him, he was unlucky to meet such stars there as the teachers at school and lyceum were and who could even more captivate him with certain ideas.
This project was preceded by several events: participation in two innovative competitions and a meeting with future partners. He was invited to the "Formula for Success" competition held by the MSU Science Park when he was in graduate school. And he even
"After all, I have always loved these mysterious interactions of molecules, since childhood: if you draw a diagram of the interaction of all molecules in a cell, you will get a picture of a "black square". And until you learn to understand the interaction of all points in this darkness, many problems will not be solved," says Hermes. However, this time he chose to simulate the interactions of proteins in the cell associated with various diseases with low—molecular compounds - potential medicinal substances. The choice, in fact, was ambiguous. Several dozen groups in the world are engaged in the creation of such programs, but they have not achieved significant success, and therefore the main consumer of such a product — pharmaceutical companies — has a very skeptical attitude towards it. Yes, they use the best practices of drag designers, but as an additional method and when there are funds for it. Basically, they rely on traditional chemical screening. "However, a company can find a connection experimentally in a week and a million dollars, and with the help of modeling — in the same week, or maybe less, and several thousand dollars," Hermes emphasizes. But only if there is a program that will guarantee the result one hundred percent."
So Hermes chose both a scientific challenge and, if successful, a revolution in the market for finding the optimal interaction of molecules. His partners in this project showed up even earlier — he met the guys while supervising term papers and a diploma. Now there are four of them in the company: besides him, Oleg Stroganov, Fyodor Novikov and Viktor Stroylov work there. And the company "Molecular Technologies" was founded in 2007. Hermes admits that the revolution will not take place tomorrow, but for some
Hermes explains: in order to find this optimal interaction, it is necessary to explore a huge space, sorting through millions of possible configurations. The dumbest algorithm would just scan all this space and spend the lion's share of time on those areas where it won't find anything good. Meanwhile, the algorithm of "Molecular Technologies" simply "cuts off" these areas, and deals only with those in which it can quickly localize the best point for interaction. And fundamental knowledge of chemistry, physics and biology helps to find these interesting areas. Algorithms from other companies do a lot of extra work and are therefore less efficient. In addition, the method of calculating the energy of interaction of molecules is of great importance, and Moltech has also succeeded in this. The tests carried out, the results of which were published in a top scientific journal, indicate that the Moltech program is significantly ahead in accuracy of well-known commercial analogues.
Now scientists continue to improve the program. "We want to solve another difficult problem," says Hermes. "None of the programs yet takes into account the influence of water molecules in this interaction of protein and compounds. It is believed that it is absolutely impossible to fully take into account this influence. But we have ideas, and I think that in six months we will reach a new level."
But already today, the Moltech program, which is called Lead Finder, is being tested in such world pharmaceutical giants as Novartis,
Portal "Eternal youth" www.vechnayamolodost.ru15.12.2008